Press

Alcimed presentation

Press Release

Alzheimer’s: Reaching the cure within this generation

Alcimed, an innovation and new business consulting firm, remains committed to supporting the pharmaceutical industry in untangling the complex web of difficulties behind curing Alzheimer’s, a disease with one of the highest drug clinical trial failure rates.

Flying cars: Is it allowed to dream?

Zee. Aero, Kitty Hawk, Ehang, Terrafugia, and now Airbus: many players are rushing to the “flying cars” market. The concept is receiving an increasing support from the institutional, industrial and financial worlds. It is gaining in maturity, and some start-ups promise to take it to the market next year. However, it remains certain that this market will not take off before a long time.

Alcimed is imagining the hospital of the future

With the emergence of new technologies, the ageing population and the increasing of chronic diseases, the hospital, as known today, will go through massive changes in the next twenty years. Alcimed imagines the three wings that might constitute the hospital of the future in 2035.

Treatment adherence: The most important unmet need in healthcare

Alcimed, an innovation and new business consulting firm, looks at the causes and consequences of non-adherence to medications and stresses the necessity to develop efficient solutions to what is arguably the most important unmet need across the entire healthcare ecosystem.

Open innovation or how to reinvent new forms of collaboration between start-ups and large groups

Open innovation, or the ability to innovate beyond one's usual boundaries, has gained in importance during the last 10 years with the deployment of digital tools. In particular, we see it represented today by various forms of partnerships between large groups and players in their ecosystems, especially with start-ups. For these 'win – win' partnerships to become sustainable, traditional working processes must be optimised.

Nutrition and public health: The strengthened role of the food processing industries in public health problems

The prevalence of conditions partly related to diet, such as obesity (the worldwide prevalence of which has doubled since 19801), but also diabetes, cardiovascular diseases, certain cancers, etc., is growing constantly. Facing this trend, the food Industry is increasingly involved in the search for solutions. Alcimed, consultants in innovation and development of new markets, is looking into the positioning of food industries against the public health issues link to nutrition.

Reduction of added sugars in solid foods: New issue and technological challenge for food companies

With the aim of improving public health, many national and international bodies are asking companies to limit the sugar intake of adults and children, encouraging them to reduce the quantity of added sugar, not only in drinks but also in solid foods. Alcimed, consultants in innovation and development of new markets, analyses the ability of the food-processing industry to face up to this issue.

Is 3D printing going to revolutionise the healthcare sector and its business model?

The technique of 3D printing has become an essential production process in the healthcare sector, where it enables unequalled customisation of the therapeutic arsenal. Alcimed, consultants in innovation and development of new markets, is considering the various applications of 3D printing in healthcare and the prospects that it offers for a profoundly-changing sector that could require the economic models in use today to be rethought.

Pioneers or followers, the industry players will all turn to the IIoT

The connected objects are more and more part of our daily lives: computers, mobile phones, but also watches, clothing and countless sensors for the home or the car. These technologies are changing the functioning of our society and our way of life. Originally associated to the consumer sphere, the Internet of Things (IoT) is more and more interesting for industrials.

Crowdsourcing: issues and benefits for pharmaceutical R&D

To optimise the R&D expenditure and support growth, pharmaceutical companies must alter their strategies. They are resorting increasingly to external innovation and particularly crowdsourcing to enable them to maintain or supplement their product pipelines.

Translational research: innovation accelerator in the pharmaceutical industry

In a relatively unproductive environment of the pharmaceutical industry, translational research offers prospects for privileged innovation and challenges the way research is currently organised. Alcimed, consultants in innovation and development of new markets, raises the issues of translational research and its impact on the development of new treatments for patients.

Contact us

Back to Top